nach oben

Applied Health Economics and Health Policy

Erschienen in:

01.09.2005 | Book Review

Evaluating pharmaceuticals for health policy and reimbursement

Edited by Nick Freemantle and Suzanne Hill. BMJ Books/Blackwell Publishing Ltd: Oxford 2004. 268 pages. ISBN 0 7279 1784 6 (paperback)

verfasst von: Jennifer A. Whitty, Paul A. Scuffham

Erschienen in: Applied Health Economics and Health Policy | Ausgabe 3/2005

Einloggen, um Zugang zu erhalten

Excerpt

‘Buy not what you want, but what you need; what you do not need is expensive at a penny. Cato, 234-149 BC’. …

Australian Government Department of Health and Ageing. Administrative guideline on the scope of the 12.5% price reduction policy (updated July 2005). Canberra (ACT): Department of Health and Ageing [online]. Available from URL: http://www.health.gov.au/internet/wcms/publishing.nsf/Content/healthpbs-pricing-adminguide/ [Accessed 2005 Aug 16]

Australian Government Department of Health and Ageing. Updated (22 April 2005) questions and answers on new pricing and listing arrangements for generic medicines on the Pharmaceutical Benefits Scheme (PBS). Canberra (ACT): Department of Health and Ageing [online]. Available from URL: http://www.health.gov.au/internet/wcms/publishing.nsf/content/health-pbspricereductions-copy2/$FILE/qa22april.pdf/ [Accessed 2005 Jun 24]

Flowers CR, Veenstra D. The role of cost-effectiveness analysis in the era of pharmacogenomics. Pharmacoeconomics 2004; 22(8): 481–93PubMedCrossRef

La Caze A. Does pharmacogenomics provide an ethical challenge to the utilisation of cost-effectiveness analysis by public health systems? Pharmacoeconomics 2005; 23(5): 445–7PubMedCrossRef

Titel: Evaluating pharmaceuticals for health policy and reimbursement
Edited by Nick Freemantle and Suzanne Hill. BMJ Books/Blackwell Publishing Ltd: Oxford 2004. 268 pages. ISBN 0 7279 1784 6 (paperback)
verfasst von: Jennifer A. Whitty
Paul A. Scuffham
Publikationsdatum: 01.09.2005
Verlag: Springer International Publishing
Erschienen in: Applied Health Economics and Health Policy / Ausgabe 3/2005
Print ISSN: 1175-5652
Elektronische ISSN: 1179-1896
DOI: https://doi.org/10.2165/00148365-200504030-00009

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Evaluating pharmaceuticals for health policy and reimbursement

Edited by Nick Freemantle and Suzanne Hill. BMJ Books/Blackwell Publishing Ltd: Oxford 2004. 268 pages. ISBN 0 7279 1784 6 (paperback)

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2005

Methodological challenges posed by economic evaluations of early childhood intervention programmes

Can we use contingent valuation to assess the demand for childhood immunisation in developing countries?

Barriers to the equitable funding of primary healthcare in South Africa

Can privatising selected services benefit the public healthcare system?

The Chinese pharmaceutical market at the crossroads

The infrastructure of obesity and the obesity epidemic